Highlights
New Otago biotech startup targets cancer
Amaroq Therapeutics, a new biotech startup company with the goal of developing targeted drugs for cancer, has been awarded si...
read the full story
Exciting building blocks unlock peptide potential
Coined ‘bacterial super villains’, the World Health Organisation has a list of ‘priority pathogens’ which have developed resi...
read the full story
Nationwide research flagship takes fight to global viral threats
A growing network of Maurice Wilkins Centre investigators around New Zealand are collaborating on research to tackle importa...
read the full story
Turning the tables on cancer
Tumours often contain areas with less oxygen than is found in normal tissues. These areas are less vulnerable to many forms o...
read the full story